- Home
- DFIN vs NEO Comparison
DFIN vs NEO Comparison
Compare DFIN & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DFIN
- NEO
- Stock Information
- Founded
- DFIN 1983
- NEO 2001
- Country
- DFIN United States
- NEO United States
- Employees
- DFIN N/A
- NEO N/A
- Industry
- DFIN Other Consumer Services
- NEO Precision Instruments
- Sector
- DFIN Consumer Discretionary
- NEO Health Care
- Exchange
- DFIN Nasdaq
- NEO Nasdaq
- Market Cap
- DFIN 1.4B
- NEO 1.2B
- IPO Year
- DFIN N/A
- NEO 1999
- Fundamental
- Price
- DFIN $44.96
- NEO $10.27
- Analyst Decision
- DFIN Strong Buy
- NEO Strong Buy
- Analyst Count
- DFIN 3
- NEO 10
- Target Price
- DFIN $68.67
- NEO $19.44
- AVG Volume (30 Days)
- DFIN 395.8K
- NEO 1.8M
- Earning Date
- DFIN 04-30-2025
- NEO 04-29-2025
- Dividend Yield
- DFIN N/A
- NEO N/A
- EPS Growth
- DFIN 13.76
- NEO N/A
- EPS
- DFIN 3.06
- NEO N/A
- Revenue
- DFIN $781,900,000.00
- NEO $660,566,000.00
- Revenue This Year
- DFIN $3.52
- NEO $13.06
- Revenue Next Year
- DFIN $4.79
- NEO $11.18
- P/E Ratio
- DFIN $14.65
- NEO N/A
- Revenue Growth
- DFIN N/A
- NEO 11.65
- 52 Week Low
- DFIN $37.80
- NEO $8.05
- 52 Week High
- DFIN $71.01
- NEO $19.11
- Technical
- Relative Strength Index (RSI)
- DFIN 55.47
- NEO 57.45
- Support Level
- DFIN $39.88
- NEO $9.81
- Resistance Level
- DFIN $42.30
- NEO $10.44
- Average True Range (ATR)
- DFIN 2.08
- NEO 0.66
- MACD
- DFIN 0.83
- NEO 0.20
- Stochastic Oscillator
- DFIN 88.20
- NEO 92.89
About DFIN Donnelley Financial Solutions Inc.
Donnelley Financial Solutions Inc is a risk and compliance solutions company. The company provides regulatory filing and deal solutions via its software-as-a-service, technology-enabled services, and print and distribution solutions to public and private companies, mutual funds, and other regulated investment firms. The company operates in four segments: Capital Markets - Software Solutions, Capital Markets - Compliance and Communications Management, Investment Companies - Software Solutions and Investment Companies - Compliance and Communications Management. Its geographical segments are the United States( USA), Europe, Asia, Canada, and others, of which the USA accounts for the vast majority of its total revenue.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.